Table 4.
Risk of cancer progression or death according to HPV, p53 and p16 status
| Model | Variable of interesta | Progression-free survival | Specific-cancer survival | |||
|---|---|---|---|---|---|---|
| HR | [CI95%] | HR | [CI95%] | |||
| 1 | HPV | 1.042 | [0.293: 3.709] | 1.901 | [0.926: 3.900] | |
| 2 | p16 | 1.137 | [0.383: 3.378] | 1.268 | [0.617: 2.604] | |
| 3 | p53 | 1.318 | [0.646: 2.689] | 1.177 | [0.726: 1.907] | |
aModel adjusted by sex. Clinical stage and treatment (surgery and chemoradiotherapy). HR: Hazard ratio